Description
An NADPH oxidase inhibitor with anti-inflammatory and antioxidant activities; inhibits NADPH oxidase complex assembly and activation, gp91phox mRNA expression, and production of the pro-inflammatory cytokines TNF-α and IL-10 in PMBCs; inhibits ROS production, iPLA2 function, and reduces Ca2+ influx through SOCs and SACs in dystrophic myotubes; reverses motor coordination deficits in the LRRK2R1441G mouse model of early Parkinson’s disease,
Formal name: 1,1′-(6,6′-dihydroxy-5,5′-dimethoxy[1,1′-biphenyl]-3,3′-diyl)bis-ethanone
Synonyms:
Molecular weight: 330.3
CAS: 29799-22-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ox Stress Reagents|Antioxidants||Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity||Research Area|Oxidative Stress & Reactive Species|Reactive Oxygen